Prostate cancer is the second most common tumor in men worldwide, with incidence rates increasing by 2-3% per year, and is becoming a major global health problem. In Western countries, prostate cancer ranks third in cancer mortality. Epidemiological data in China also shows that the incidence of prostate cancer has increased rapidly in recent years. Huang Yiran, Department of Urology, Shanghai Renji Hospital Treatment of prostate cancer that has metastasized includes endocrine therapy (including drug or surgical debulking and anti-androgen therapy) and chemotherapy. Almost all patients will eventually develop drug resistance and have limited treatment options. The Multidisciplinary Comprehensive Prostate Cancer Clinic at Renji Hospital covers urology, oncology, radiotherapy, pathology, imaging and other related departments, and provides one-stop, individualized and comprehensive treatment for prostate cancer patients through a joint multidisciplinary clinic every Monday afternoon. For patients with metastatic prostate cancer who have become insensitive to endocrine therapy, please contact Dr. Dong Bojun of the Department of Urology at Renji Hospital at Dr. Dong Bojun Every Monday afternoon, Renji Hospital (East, 1630 Dongfang Road) Prostate Cancer Personalized Treatment Specialized Outpatient Clinic Available by consultation or appointment for outpatient consultation.